Skip to main content
. 2023 May 23:1–9. Online ahead of print. doi: 10.1007/s12574-023-00603-1

Table 2.

Baseline medications in patients

(n = 22)
Angiotensin converting enzymes inhibitor 3 (13.6%)
Angiotensin receptor blocker 2 (9.1%)
Beta blocker 6 (27.2%)
Calcium channel blocker 4 (18.1%)
Diuretics 2 (9.1%)
Insulin 3 (13.6%)
Lipid-lowering agent 6 (27.2%)
Oral diabetes medications 5 (22.7%)
Anticoagulant 0 (0.0%)
Direct oral anticoagulant 0 (0.0%)
Aspirin 7 (31.8%)
Anti-arrhythmic 0 (0.0)
Immunosuppressant 1 (4.5%)